Neurology

IMU-838 daily doses of 30-mg and 45-mg suppressed the development of gadolinium-enhancing lesions by 78%…

William Hu, MD, PhD, FAAN, a neurologist at RWJBarnabas Health’s Robert Wood Johnson University Hospital…

EryDex did not meet its primary end point possibly because of delays in treatment reducing…

The postdoctoral researcher at Amsterdam University Medical Center introduces the DAAE score, a tool used…

DT-216P2 shows promise in treating patients with Friedreich ataxia based on positive phase 1 trial…

The director of academic clinical research at Orlando Health reflected on the journey of a…

PTC Therapeutics has plans to submit a new drug application for vatiquinone, a small molecule…

The assistant professor of neurology at Cleveland Clinic talked about a validated dimensional scale presented…

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 23,…

The director of academic clinical research at Orlando Health talked about applying Abbott's blood test…